P

Precision Cancer Centers | Ashland-Bellefonte Cancer Center

Research site
(Unclaimed)
Location
122 Street Christopher Drive, Ashland, Kentucky, United States of America

Site insights

Top conditions

Top treatments

Estrogen
Neratinib
Docetaxel
Luspatercept
Injectafer
Palonosetron
Pembrolizumab
-Clivatuzumab
Pegfilgrastim
Debio 1143

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

This Phase II, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant compared with physician's choice of en...

Active, not recruiting
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Drug: Fulvestrant or an Aromatase Inhibitor (Physician Choice)
Drug: LHRH Agonist

The primary objective of the study is to demonstrate superior efficacy of Xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in...

Active, not recruiting
Squamous Cell Carcinoma of the Head and Neck
Drug: Placebo
Drug: Xevinapant (Debio 1143)

Trial sponsors

Puma Biotechnology logo
Roche logo
American Regent logo
Celgene logo
G
Gilead Sciences logo
H
H
Merck KGaA (EMD Serono) logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems